Literature DB >> 33855683

Evaluation of the Ameliorative Effect of Zinc Nanoparticles against Silver Nanoparticle-Induced Toxicity in Liver and Kidney of Rats.

Asmaa M Shehata1, Fatma M S Salem1, Eiman M El-Saied1, Sahar S Abd El-Rahman2, Mohamed Y Mahmoud1, Peter A Noshy3.   

Abstract

Silver nanoparticles (Ag-NPs) have various pharmaceutical and biomedical applications owing to their unique physicochemical properties. Zinc (Zn) is an essential trace element, a strong antioxidant, and has a primary role in gene expression, enzymatic reactions, and protein synthesis. The present study aims to explore the toxic effects of Ag-NPs (50 nm) on the liver and kidney of rats and also to evaluate the potential protective effect of Zn-NPs (100 nm) against these adverse effects. Forty adult Sprague-Dawley rats were randomly divided into four equal groups: control group, Ag-NPs group, Zn-NPs group, and Ag-NPs + Zn-NPs group. Ag-NPs (50 mg/kg) and/or Zn-NPs (30 mg/kg) were administered daily by gavage for 90 days. The results showed that exposure to Ag-NPs increased serum ALT, AST, urea, and creatinine. Ag-NPs also induced oxidative stress and lipid peroxidation and increased inflammatory cytokines in hepatic and renal tissues. Moreover, histopathological and immunohistochemical examinations revealed various histological alterations and positive caspase-3 expressions in the liver and kidney following exposure to Ag-NPs. On the other hand, most of these toxic effects were ameliorated by co-administration of Zn-NPs. It was concluded that Ag-NPs have hepatotoxic and nephrotoxic effects in rats via different mechanisms including oxidative stress, inflammation, and apoptosis and that Zn-NPs can be used to alleviate these harmful effects by their antioxidative, anti-inflammatory, and antiapoptotic properties.
© 2021. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.

Entities:  

Keywords:  Antioxidants; Caspase-3; Hepatotoxicity; Inflammatory cytokines; Lipid peroxidation; Nephrotoxicity

Mesh:

Substances:

Year:  2021        PMID: 33855683     DOI: 10.1007/s12011-021-02713-2

Source DB:  PubMed          Journal:  Biol Trace Elem Res        ISSN: 0163-4984            Impact factor:   3.738


  33 in total

1.  The effect of agglomeration state of silver and titanium dioxide nanoparticles on cellular response of HepG2, A549 and THP-1 cells.

Authors:  Anna Lankoff; Wiggo J Sandberg; Aneta Wegierek-Ciuk; Halina Lisowska; Magne Refsnes; Bożena Sartowska; Per E Schwarze; Sylwia Meczynska-Wielgosz; Maria Wojewodzka; Marcin Kruszewski
Journal:  Toxicol Lett       Date:  2011-11-15       Impact factor: 4.372

2.  Increased oxidative stress and activated heat shock proteins in human cell lines by silver nanoparticles.

Authors:  L Xin; J Wang; Y Wu; S Guo; J Tong
Journal:  Hum Exp Toxicol       Date:  2014-06-30       Impact factor: 2.903

Review 3.  Pharmacokinetics of metallic nanoparticles.

Authors:  Zhoumeng Lin; Nancy A Monteiro-Riviere; Jim E Riviere
Journal:  Wiley Interdiscip Rev Nanomed Nanobiotechnol       Date:  2014-10-15

4.  Repeated-dose toxicity and inflammatory responses in mice by oral administration of silver nanoparticles.

Authors:  Eun-Jung Park; Eunjoo Bae; Jongheop Yi; Younghun Kim; Kyunghee Choi; Sang Hee Lee; Junheon Yoon; Byung Chun Lee; Kwangsik Park
Journal:  Environ Toxicol Pharmacol       Date:  2010-05-19       Impact factor: 4.860

5.  Antimicrobial activity of zinc oxide particles on five micro-organisms of the Challenge Tests related to their physicochemical properties.

Authors:  Julia Pasquet; Yves Chevalier; Emmanuelle Couval; Dominique Bouvier; Gaëlle Noizet; Cécile Morlière; Marie-Alexandrine Bolzinger
Journal:  Int J Pharm       Date:  2013-11-07       Impact factor: 5.875

6.  Investigating oxidative stress and inflammatory responses elicited by silver nanoparticles using high-throughput reporter genes in HepG2 cells: effect of size, surface coating, and intracellular uptake.

Authors:  Raju Y Prasad; John K McGee; Micaela G Killius; Danielle A Suarez; Carl F Blackman; David M DeMarini; Steven O Simmons
Journal:  Toxicol In Vitro       Date:  2013-07-17       Impact factor: 3.500

7.  Effects of silver nanoparticles on the liver and hepatocytes in vitro.

Authors:  Birgit K Gaiser; Stephanie Hirn; Ali Kermanizadeh; Nilesh Kanase; Kleanthis Fytianos; Alexander Wenk; Nadine Haberl; Andrea Brunelli; Wolfgang G Kreyling; Vicki Stone
Journal:  Toxicol Sci       Date:  2012-10-19       Impact factor: 4.849

Review 8.  Zinc deficiency, DNA damage and cancer risk.

Authors:  Emily Ho
Journal:  J Nutr Biochem       Date:  2004-10       Impact factor: 6.048

9.  Sub-chronic Dermal Toxicity of Silver Nanoparticles in Guinea Pig: Special Emphasis to Heart, Bone and Kidney Toxicities.

Authors:  Mitra Korani; Seyed Mahdi Rezayat; Sepideh Arbabi Bidgoli
Journal:  Iran J Pharm Res       Date:  2013       Impact factor: 1.696

10.  Effect of long-term administration of Cinnamomum cassia silver nanoparticles on organs (kidneys and liver) of Sprague-Dawley rats.

Authors:  Kofi Kouame; Aniekan Imo Peter; Edidiong Nnamso Akang; Misturah Adana; Roshila Moodley; Edwin Coleridge Naidu; Onyemaechi Okpara Azu
Journal:  Turk J Biol       Date:  2018-12-10
View more
  2 in total

1.  Silver Nanoparticles Enhance Oxidative Stress, Inflammation, and Apoptosis in Liver and Kidney Tissues: Potential Protective Role of Thymoquinone.

Authors:  Basma Salama; Khalid J Alzahrani; Khalid S Alghamdi; Osama Al-Amer; Khalid E Hassan; Mohamed A Elhefny; Alaa Jameel A Albarakati; Fahad Alharthi; Hussam A Althagafi; Hassan Al Sberi; Hatem K Amin; Maha S Lokman; Khalaf F Alsharif; Ashraf Albrakati; Ahmed E Abdel Moneim; Rami B Kassab; Ayah S Fathalla
Journal:  Biol Trace Elem Res       Date:  2022-08-26       Impact factor: 4.081

2.  Protective effects of silver nanoparticles in isoproterenol-induced myocardial infarction in rats.

Authors:  Wawaimuli Arozal; Edwina Rogayah Monayo; Agian Jeffilano Barinda; Dian Pribadi Perkasa; Vivian Soetikno; Nafrialdi Nafrialdi; Melva Louisa
Journal:  Front Med (Lausanne)       Date:  2022-08-25
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.